載入...
Standardizing total kidney volume measurements for clinical trials of autosomal dominant polycystic kidney disease
BACKGROUND: The ability of unstandardized methods to track kidney growth in clinical trials for autosomal dominant polycystic kidney disease (ADPKD) has not been critically evaluated. METHODS: The Tolvaptan Efficacy and Safety Management of ADPKD and its Outcomes (TEMPO) 3:4 study involved baseline...
Na minha lista:
| 發表在: | Clin Kidney J |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Oxford University Press
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6366146/ https://ncbi.nlm.nih.gov/pubmed/30746130 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ckj/sfy078 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|